文献速递泌尿与男性生殖病理细胞病理与分子病理

乳头状尿路上皮癌侧向延伸的组织学与分子特征:对分类和治疗的意义

Histological and molecular characterization of lateral extension in papillary urothelial carcinoma: implications for classification and management
RSS 订阅 · Histopathology · 2026-10-30

该研究对25例患者的37份整块经尿道切除标本进行组织学、免疫组化和分子分析,发现乳头状尿路上皮癌的侧向延伸可较长且形态异质,多数与邻近癌克隆相关,不应视为原位癌。

要点

  • 侧向延伸平均长度4.7mm,范围1.5-10.8mm,可延伸至黏膜切缘。
  • 82%(9/11)的侧向延伸与邻近癌共享致病/可能致病变异,支持克隆相关性。
  • 侧向延伸可显示类似原位癌的CK20和p53免疫组化模式,需注意鉴别。

核心结论

  • 侧向延伸可延伸至少1cm,若追求完整手术切除应考虑更宽的切除边缘。
  • 侧向延伸多数与邻近乳头状尿路上皮癌克隆相关,但分子和免疫组化关系异质。
  • 侧向延伸可显示类似原位癌的免疫组化表现,识别它有助于提高诊断一致性并减少过度诊断。

研究设计与样本

  • 研究纳入25例患者的37份整块经尿道切除标本。
  • 对乳头状尿路上皮癌和侧向延伸成分进行形态学、免疫组化和分子特征分析。
  • 对11/13例有侧向延伸的肿瘤进行配对下一代测序。

主要发现

  • 侧向延伸形态分为三种模式:无侧向延伸(n=24)、低于邻近癌级别(n=10)、与邻近癌级别相似(n=3)。
  • 侧向延伸平均长度4.7mm(范围1.5-10.8mm),12/13(92%)延伸至黏膜切缘。
  • 9/11(82%)的侧向延伸与邻近癌共享至少一部分致病/可能致病变异,支持克隆性。
  • 5例肿瘤存在乳头状尿路上皮癌特有的额外变异,伴或不伴侧向延伸特有变异。
  • CK20异常见于11/11例侧向延伸,p53异常见于3/11(27%);p53染色一致10/11(91%),CK20一致仅6/11(55%)。

临床怎么用

  • 病理诊断中应识别侧向延伸,避免将其误判为原位癌。
  • 手术切除时若追求完整切除,应考虑侧向延伸可能延伸至1cm以上,需更宽的切缘。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We perform histological, immunohistochemical and molecular characterization of lateral extension (LE) in papillary urothelial carcinoma (PUC). We find that LE can be relatively extensive and is morphologically and immunohistochemically heterogenous. Importantly, most are clonally related to the adjacent PUC and should not be considered as urothelial carcinoma in situ. Introduction Lateral extension (LE) in urinary bladder papillary urothelial carcinoma (PUC) refers to the phenomenon where atypical urothelium is seen extending laterally in a flat configuration from the base of the papillary tumour. LE is recognized but poorly defined, resulting in inconsistent diagnoses and interpretations amongst pathologists, ranging from atypia to carcinoma in situ (CIS). Herein, we aim to better characterize LE in high-grade PUC, utilizing en bloc transurethral resection specimens. Methods We reviewed 37 en bloc specimens from 25 patients and performed comprehensive morphological, molecular and immunohistochemical characterization of PUC and LE components. Results Three morphological patterns were seen: no LE (n = 24), LE with lower-grade cytomorphology compared to adjacent PUC (lower-grade LE, n = 10), and LE with cytomorphology similar to adjacent PUC (higher-grade LE, n = 3). Mean LE length was 4.7 mm (range 1.5–10.8 mm). LE extended to mucosal margins in 12/13 (92%). Differential next-generation sequencing was performed on paired PUC and adjacent LE components in 11/13 tumours with LE. In 9/11 (82%), LE and PUC showed at least a subset of shared pathogenic/likely pathogenic alterations, supporting clonality between the two components; in five tumours, there were additional alterations specific to PUC, with and without LE-specific alterations. Immunohistochemical staining for CK20 and p53 showed LE with abnormal CK20 in all 11/11 tumours and aberrant p53 in 3/11 (27%). PUC and LE showed concordant p53 staining patterns in 10/11 (91%) and CK20 in only 6/11 (55%) specimens. Conclusion We find that LE can extend at least 1 cm from the base of PUC, suggesting consideration for wider resection margins if complete surgical resection is desired. Additionally, LE is clonally related to PUC in most cases, albeit with heterogeneous relationships, as evidenced by both molecular and immunohistochemical findings. Notably, LE can show immunohistochemical findings similar to those commonly reported for CIS. Recognition of LE may improve diagnostic consistency and reduce overdiagnos

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Histopathology:Histological and molecular characterization of lateral extension in papillary urothelial carcinoma: implications for classification and management

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。